for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Danaher Corporation

DHR.N

Latest Trade

138.01USD

Change

0.24(+0.17%)

Volume

603,778

Today's Range

137.03

 - 

138.58

52 Week Range

94.62

 - 

147.32

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Beckman Coulter's DxA 5000 Total Laboratory Automation Solution Receives U.S. FDA 510(k) Clearance

Oct 9 (Reuters) - Beckman Coulter::BECKMAN COULTER'S DXA 5000 TOTAL LABORATORY AUTOMATION SOLUTION RECEIVES U.S. FDA 510(K) CLEARANCE.BECKMAN COULTER - DXA 5000 TOTAL LABORATORY AUTOMATION SOLUTION HAS RECEIVED FDA 510(K) CLEARANCE AND IS NOW AVAILABLE FOR SALE IN U.S..

Danaher Announces Redemption Of Senior Notes

Sept 23 (Reuters) - Danaher Corp <DHR.N>::DANAHER ANNOUNCES REDEMPTION OF SENIOR NOTES.DANAHER CORP - WILL REDEEM ALL OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.400% SENIOR NOTES DUE 2020.DANAHER CORP - WILL REDEEM ALL OF $375 MILLION AGGREGATE PRINCIPAL AMOUNT OF 5.00% SENIOR NOTES DUE 2020.DANAHER CORP - REDEMPTION DATE FOR NOTES WILL BE OCTOBER 24, 2019.DANAHER - INTENDS TO FUND REDEMPTION USING PORTION OF CASH DISTRIBUTION FROM IPO OF ENVISTA HOLDINGS.

Envista Holdings Corp Shares Open 16.6% Above IPO Price In Debut

Sept 18 (Reuters) - Envista Holdings Corp <NVST.N>::ENVISTA HOLDINGS CORP SHARES OPEN AT $25.65 IN DEBUT ON NYSE VERSUS IPO PRICE OF $22.00/SHARE.

Envista Announces Pricing Of Initial Public Offering

Sept 17 (Reuters) - Envista Holdings Corporation <NVST.N>::ENVISTA HOLDINGS CORP SAYS PRICING OF ITS INITIAL PUBLIC OFFERING (IPO) OF 26.77 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $22 /SHARE.ENVISTA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.

Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

Sept 3 (Reuters) - Danaher Corp <DHR.N>::DANAHER ANNOUNCES PRICING OF EURO-DENOMINATED SENIOR NOTES OFFERING.DANAHER CORP-CO UNIT DH EUROPE FINANCE II S.À R.L. PRICED OFFERING OF EUR1.25 BILLION PRINCIPAL AMOUNT OF 0.200% SENIOR NOTES DUE 2026 AT PRICE OF 99.833%.DANAHER CORP-CO UNIT DH EUROPE FINANCE II S.À R.L. PRICED OFFERING OF EUR1.75 BILLION PRINCIPAL AMOUNT OF 0.750% SENIOR NOTES DUE 2031 AT PRICE OF 99.920%.DANAHER CORP-CO UNIT DH EUROPE FINANCE II S.À R.L. PRICED OFFERING OF EUR1.25 BILLION PRINCIPAL AMOUNT OF 1.350% SENIOR NOTES DUE 2039 AT PRICE OF 99.461%.DANAHER CORP-CO UNIT DH EUROPE FINANCE II S.À R.L. PRICED OFFERING OF EUR750 MILLION PRINCIPAL AMOUNT OF 1.800% SENIOR NOTES DUE 2049 AT PRICE OF 99.564%.DANAHER CORP-CO UNIT DH EUROPE FINANCE II S.À R.L PRICED OFFERING OF EUR1.25 BILLION PRINCIPAL AMOUNT OF 0.450% SENIOR NOTES DUE 2028 AT PRICE OF 99.751%.

Danaher Posts Q2 Earnings Per Share of $0.97

July 18 (Reuters) - Danaher Corp <DHR.N>::DANAHER REPORTS SECOND QUARTER 2019 RESULTS.SEES Q3 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.12 TO $1.15.SEES FY 2019 EARNINGS PER SHARE $3.38 TO $3.43.SEES Q3 2019 EARNINGS PER SHARE $0.86 TO $0.89.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.19.Q2 REVENUE $5.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $5.08 BILLION.Q2 EARNINGS PER SHARE $0.97.Q2 EARNINGS PER SHARE ESTIMATE $1.16 -- REFINITIV IBES DATA.RAISES FY 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE VIEW TO $4.75 TO $4.80.FY2019 EARNINGS PER SHARE VIEW $4.78 -- REFINITIV IBES DATA.Q3 EARNINGS PER SHARE VIEW $1.16 -- REFINITIV IBES DATA.CONTINUE TO MAKE PROGRESS ON ANTICIPATED ACQUISITION OF GE BIOPHARMA.CONTINUE TO MAKE PROGRESS ONPLANNED INITIAL PUBLIC OFFERING OF DENTAL BUSINESS, WHICH WILL BE CALLED ENVISTA.

Danaher Corp Files For Potential Mixed Shelf Offering; Size Not Disclosed

July 2 (Reuters) - Danaher Corp <DHR.N>::DANAHER CORP FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.

Danaher Says To Create And Take Public New Co Named Envista Holdings Corp

June 27 (Reuters) - Danaher Corp <DHR.N>::DANAHER ANNOUNCES NEW DENTAL COMPANY TO BE NAMED ENVISTA HOLDINGS CORPORATION.ENVISTA HOLDINGS CORP TO BE NAME OF SEPARATE COMPANY DANAHER INTENDS TO CREATE AND TAKE PUBLIC VIA IPO IN SECOND HALF OF 2019.ENVISTA TO BE COMPRISED OF THREE OPERATING COMPANIES WITHIN DANAHER'S DENTAL SEGMENT: NOBEL BIOCARE SYSTEMS, KAVO KERR, AND ORMCO.ENVISTA INTENDS TO APPLY TO LIST ITS COMMON STOCK ON NEW YORK STOCK EXCHANGE. STOCK SYMBOL WILL BE NVST.

FDA Alerts About Recall Of Beckman Coulter Blood Test Analyzers

May 23 (Reuters) - U.S. Food and Drug Administration::FDA - ALERTS ABOUT RECALL OF BECKMAN COULTER BLOOD TEST ANALYZERS DUE TO RISK OF INACCURATE PLATELET ANALYZING RESULTS.FDA - HAS NOT RECEIVED REPORTS OF SERIOUS ADVERSE EVENTS LINKED DIRECTLY TO BECKMAN COULTER HEMATOLOGY ANALYZERS.FDA SAYS ALERTING HOSPITALS, LABORATORIES & PROVIDERS OF A CLASS 1 RECALL OF BECKMAN COULTER DXH 800, DXH 600 & DXH 900 HEMATOLOGY ANALYZERS-DEVICES.

Third Point Cuts Share Stake In Constellation Brands

May 15 (Reuters) - THIRD POINT LLC::THIRD POINT LLC CUTS SHARE STAKE IN CONSTELLATION BRANDS INC BY 40.0 PERCENT TO 1.1 MILLION CLASS A SHARES - SEC FILING.THIRD POINT LLC TAKES SHARE STAKE OF 2.0 MILLION SHARES IN CHEMOURS CO.THIRD POINT LLC UPS SHARE STAKE IN DANAHER CORP BY 19.3 PERCENT TO 3.7 MILLION SHARES.THIRD POINT LLC: CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2019 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DECEMBER 31, 2018.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up